BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: Trading Halt, page-25

  1. 4,850 Posts.
    lightbulb Created with Sketch. 801
    Last four months has seen two credit raises, and one FDA approval extension due to labeling errors. Not the best effort from our management team, was expecting perhaps one CR then FDA approval and a Share price of 30c, hope they don’t get a Christmas bonus.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.